The federal government is expanding the capacity of Canada’s level-4 containment labs in Winnipeg, which are used to research some of the world’s most dangerous human and animal diseases.
Health Minister Jane Philpott announced the $5-million lab expansion today in Winnipeg, saying the enhancements are critical for strengthening Canada’s ability to respond to both global and domestic public health threats.
Get weekly health news
RELATED: Lead Ebola scientist Gary Kobinger leaving national lab in Winnipeg
The increased lab space will help improve testing and researching of high-risk infectious diseases like Ebola, Middle East respiratory syndrome and avian influenza.
Level-4 labs provide the highest degree of biocontainment and are equipped to safely diagnose, research and develop treatments and vaccines for high-risk pathogens.
- Nova Scotian mothers bring attention to perinatal mental health care, call for more resources
- Ontario paramedics launch medical drone pilot to speed delivery of life-saving equipment
- Moncton wastewater reveals methamphetamine levels among highest in Canada
- Congo running short of health workers as Ebola outbreak spreads, WHO says
Scientists at the National Microbiology Laboratory have improved diagnosis and developed an experimental vaccine for Ebola, while also working on treatments for other level-4 diseases like Lassa fever and the Marburg virus.
RELATED: Ebola vaccine developed in Winnipeg being put to the test
Researchers at the lab are also studying Nipah virus — a potentially fatal disease that can affect both pigs and humans.
Comments
Want to discuss? Please read our Commenting Policy first.